The results showed that EREG-induced PDL1 was significantly suppressed in presence of EGFR inhibitors, suggesting that activated EGFR is essential for PDL1 induction in HNSCC cells (Fig. 2d). This evidence concerns the gene EREG and head and neck squamous cell carcinoma.